Research finds link between unhealthy eating and chronic pain severity, calls for comprehensive dietary support

John­son & John­son put down $400 mil­lion up­front to ac­quire Lam­i­nar, a med­ical de­vice com­pa­ny fo­cused on re­duc­ing the risk of stroke for pa­tients with

Sanofi is su­ing Sarep­ta Ther­a­peu­tics, al­leg­ing that the com­pa­ny’s ap­proved mus­cu­lar dy­s­tro­phy treat­ment in­fringes on its patents re­lat­ed to the chem­i­cal make­up of the prod­uct